The Trip Report
Un podcast de Beckley Waves - Les jeudis
Catégories:
38 Épisodes
-
Special Dispatch: An Election Retrospective with Nick Gillespie
Publié: 13/11/2024 -
#35 Lucia Huang: Innovative Solutions in Neuropsychiatry
Publié: 31/10/2024 -
#34 Shamil Chandaria: Computational Neuroscience and Human Flourishing
Publié: 17/10/2024 -
#33 Rock Feilding-Mellen: Building the Future of the Psychedelic Field
Publié: 03/10/2024 -
#32 Rachelle Sampson & Bennet Zelner: The Connected Leadership Study
Publié: 19/09/2024 -
Ep #31 Rebecca Kronman: Psychedelics & Parenting
Publié: 05/09/2024 -
Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy
Publié: 22/08/2024 -
Special Dispatch: FDA Rejects Lykos’ MDMA Assisted Therapy Application
Publié: 13/08/2024 -
#29 Dr. Selma Holden MD: All Eyes on the FDA
Publié: 08/08/2024 -
#28 East Forest: Music for Mushrooms
Publié: 25/07/2024 -
#27 Joanna Kempner: Psychedelic Outlaws
Publié: 11/07/2024 -
#26 Brandon Kapelow: ‘An Act of Service’- A Journey Through PTSD and Ketamine Therapy
Publié: 27/06/2024 -
#25 Christof Koch: Exploring Consciousness and Perception
Publié: 13/06/2024 -
#24 Manesh Girn Ph.D. - Exploring the Psychedelic Brain and Human Potential
Publié: 30/05/2024 -
#23 Dennis Walker: The Court Jester of Psychedelics
Publié: 16/05/2024 -
#22 Bruce Damer: Catalyzing Scientific and Creative Breakthroughs
Publié: 02/05/2024 -
#21: Pedro Teixeira, Ph.D. - Psychedelics and Health Behavior Change
Publié: 18/04/2024 -
#20: Jackie von Salm, Ph.D. - Natural Products & Novel Therapies
Publié: 04/04/2024 -
#19 Beckley Academy: Charting the Course for Psychedelic-Assisted Therapy
Publié: 21/03/2024 -
#18 Rick Doblin: The Path to MDMA Approval and Beyond
Publié: 07/03/2024
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com
